Table: Cyfuse Biomedical - Q1 parent results

Cyfuse Biomedical KK

15/05/2023 07:45

May 15 (Reuters)- 
             Cyfuse Biomedical K.K. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Mar 31, 2023        Mar 31, 2022      Dec 31, 2023  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             7 mln                                604 mln    
                                                       (+61.5 pct)  
  Operating     loss 172 mln                          loss 833 mln  
  Recurring     loss 167 mln                          loss 680 mln  
  Net           loss 168 mln                          loss 682 mln  
  EPS          loss 21.56 yen                        loss 87.78 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Cyfuse Biomedical K.K.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T